The ROE as of December 2024 (TTM) for iCAD, Inc. (ICAD) is -10.78%

According to iCAD, Inc.’s latest financial reports and current stock price. The company's current ROE is -10.78%. This represents a change of 276.86% compared to the average of -2.86% of the last 4 quarters.

iCAD, Inc. (ICAD) Historical ROE (quarterly & annually)

How has ICAD ROE performed in the past?

The mean historical ROE of iCAD, Inc. over the last ten years is -77.44%. The current -10.78% ROE has changed -86.08% with respect to the historical average. Over the past ten years (40 quarters), ICAD's ROE was at its highest in in the December 2023 quarter at 4.08%. The ROE was at its lowest in in the March 2019 quarter at -81.41%.

iCAD, Inc. (ICAD) ROE by Quarter and Year

Discovering the peaks and valleys of iCAD, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

iCAD, Inc. (ICAD) Average ROE

How has ICAD ROE performed in the past?

The current ROE of iCAD, Inc. (ICAD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

iCAD, Inc. (ICAD) ROE vs. Peers

How is ICAD’s ROE compared to its peers?

iCAD, Inc.’s ROE is greater than Profound Medical Corp. (-85.22%), greater than SI-BONE, Inc. (-22.51%), greater than Sight Sciences, Inc. (-47.28%), greater than Nevro Corp. (-24.76%), greater than Paragon 28, Inc. (-38.77%), greater than STRATA Skin Sciences, Inc. (-91.63%), less than Sientra, Inc. (95.70%), greater than AxoGen, Inc. (-14.91%), greater than Ainos, Inc. (-75.16%), greater than LENSAR, Inc. (-43.49%), less than Aziyo Biologics, Inc. (124.47%), less than INVO Bioscience, Inc. (0%), greater than enVVeno Medical Corporation (-48.73%), greater than Establishment Labs Holdings Inc. (-184.55%), greater than CVRx, Inc. (-89.06%), less than Surgalign Holdings, Inc. (624.34%), greater than Surmodics, Inc. (-9.56%), greater than Biomerica, Inc. (-84.62%), greater than Movano Inc. (-345.78%),

Build a custom stock screener for iCAD, Inc. (ICAD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like iCAD, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

iCAD, Inc. (ICAD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like iCAD, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.